MedPath

Tim-Brim-Dor-Lat

Approved
Approval ID

6ba4f0b3-d776-3485-e053-2991aa0abab3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2018

Manufacturers
FDA

ImprimisRx NJ

DUNS: 931390178

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Timolol - Brimonidine - Dorzolamide - Latanoprost

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70261-522
Product Classification
G
Generic Name
Timolol - Brimonidine - Dorzolamide - Latanoprost
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 8, 2018
FDA Product Classification

INGREDIENTS (4)

DORZOLAMIDE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: QZO5366EW7
Classification: ACTIM
TIMOLOL MALEATEActive
Quantity: 5 mg in 1 mL
Code: P8Y54F701R
Classification: ACTIM
BRIMONIDINE TARTRATEActive
Quantity: 1.5 mg in 1 mL
Code: 4S9CL2DY2H
Classification: ACTIB
LATANOPROSTActive
Quantity: 0.05 mg in 1 mL
Code: 6Z5B6HVF6O
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.